tiprankstipranks
Trending News
More News >
Photocure ASA (PHCUF)
OTHER OTC:PHCUF
US Market
Advertisement

Photocure ASA (PHCUF) Earnings Dates, Call Summary & Reports

Compare
9 Followers

Earnings Data

Report Date
Feb 25, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
Last Year’s EPS
-0.02
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 29, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted Photocure's strong product growth, strategic market expansions, and positive financial performance, despite challenges in the Flex segment and foreign exchange impacts. The company is well-positioned for future growth with innovative partnerships and a strong cash flow position.
Company Guidance
In the third quarter of 2025, Photocure reported a 12% increase in global product revenue, rising to NOK 134 million, with a 14% growth in unit sales in North America, despite foreign exchange impacts. The company achieved a positive EBITDA of NOK 10.2 million, marking the tenth consecutive quarter of positive EBITDA. In North America, the rigid surgical market grew by 20%, and the active accounts increased by 23% year-over-year. The European market also showed strong performance with an 11% revenue increase, driven by upgrades like the Olympus Visera III. Photocure's strategic initiatives, including the collaboration with Intelligent Scopes Corporation for AI development in Blue Light Cystoscopy, are expected to enhance detection accuracy and support future growth. The company maintains a strong balance sheet with NOK 247.8 million in cash and no term debt, positioning itself for long-term success in the bladder cancer diagnostic space.
Strong Product Growth
Photocure experienced a 12% product growth globally, with North America delivering 14% unit growth and 12% product revenue growth. The installed base of Saphira Blue Light equipment increased with 7 new tower placements and 7 upgrades in the U.S.
Significant European Market Expansion
Revenue in Europe was up 11%, with strong growth in the Nordics and DACH regions driven by Olympus upgrades of the Visera III system. Active accounts increased by 23% year-over-year to 373 accounts.
Positive Financial Metrics
Photocure reported a positive EBITDA of NOK 10.2 million, marking the 10th consecutive quarter of positive EBITDA. The company has a strong balance sheet with NOK 247.8 million in cash and no term debt.
Strategic Partnerships and Innovations
Photocure announced a strategic partnership with Intelligent Scopes Corporation to develop AI software for real-time tumor detection using Blue Light Cystoscopy. The ENABLE clinical study is initiated in both the U.S. and Europe.
Operational Leverage and Cash Flow
Achieved improved operating leverage with year-to-date cash flow from operations positive at NOK 26.4 million. Excluding the share buyback program, Photocure had a positive net cash flow of NOK 16.5 million year-to-date.

Photocure ASA (PHCUF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

PHCUF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 25, 2026
2025 (Q4)
- / -
-0.022
Oct 29, 2025
2025 (Q3)
>-0.01 / 0.01
-0.013215.38% (+0.03)
Jul 30, 2025
2025 (Q2)
>-0.01 / <0.01
0.045-84.51% (-0.04)
May 08, 2025
2025 (Q1)
>-0.01 / >-0.01
-0.02969.07% (+0.02)
Feb 19, 2025
2024 (Q4)
0.02 / -0.02
0.046-148.26% (-0.07)
Nov 13, 2024
2024 (Q3)
-0.02 / -0.01
-0.01726.14% (<+0.01)
Aug 07, 2024
2024 (Q2)
0.03 / 0.04
0.016182.50% (+0.03)
May 15, 2024
2024 (Q1)
-0.03 / -0.03
-0.04332.33% (+0.01)
Feb 21, 2024
2023 (Q4)
-0.01 / 0.05
-0.092149.46% (+0.14)
Nov 08, 2023
2023 (Q3)
-0.04 / -0.02
-0.02426.67% (<+0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

PHCUF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 29, 2025
$5.37$5.44+1.30%
Jul 30, 2025
$5.94$5.940.00%
May 08, 2025
$4.32$4.320.00%
Feb 19, 2025
$5.02$4.63-7.77%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Photocure ASA (PHCUF) report earnings?
Photocure ASA (PHCUF) is schdueled to report earning on Feb 25, 2026, Before Open (Confirmed).
    What is Photocure ASA (PHCUF) earnings time?
    Photocure ASA (PHCUF) earnings time is at Feb 25, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is PHCUF EPS forecast?
          Currently, no data Available
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis